Understanding short bowel syndrome: Current status and future perspectives

Area of Science:

• Gastroenterology
• Surgical Oncology
• Transplant Surgery

Background:

• Short bowel syndrome (SBS) is a rare malabsorptive disorder resulting from significant small intestine loss, often due to surgical resection.
• Causes include vascular diseases, neoplasms, and inflammatory bowel disease, with severity varying from micronutrient malabsorption to complete intestinal failure.

Purpose of the Study:

• To review current literature on SBS epidemiology, pathophysiology, and management.
• To highlight recent advances in surgical and medical treatments, including teduglutide.
• To discuss approaches to managing SBS complications like sepsis and liver disease.

Main Methods:

• Comprehensive literature review of SBS.
• Analysis of surgical interventions such as intestinal lengthening and transplantation.
• Evaluation of medical management strategies, including parenteral nutrition and pharmacotherapy.

Main Results:

• Significant improvements in patient quality of life and survival due to advances in home-based parenteral nutrition.
• Emergence of new treatment strategies and drugs, notably teduglutide, enhancing SBS management.
• Growing understanding and updated approaches to managing SBS-related complications.

Conclusions:

• SBS management has markedly improved, enhancing patient outcomes.
• Teduglutide and other advancements offer new dimensions in treating SBS.
• Continued research and updated approaches are crucial for managing SBS and its complications.